BioSpace News Archive

Data driven solution to be made available for millions of consumers with social determinants of health (SDOH) improving medical adherence, elderly loneliness and positive outcomes.

Signify Health has announced the launch of Signify Community, the first and only social determinants of health solution that ties social interventions to quality, satisfaction, and financial outcomes—including 30% reductions in readmissions and 46% reductions in post-acute care spend for high-utilizer safety net populations.

Funds support the completion of ongoing Phase 2b study in Oral Lichen Planus

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it will release its financial results for the second quarter of 2019 before the market opens on Wednesday, July 24, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT.

Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA)

Phreesia announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock.

Craneware (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today announced it will be joining Moffitt Cancer Center at the HFMA Annual Conference 2019 to discuss how the organizations are partnering to gain an understanding of AI, and its application to charge capture and denials management

Epilepsy Foundation, the largest national epilepsy advocacy organization, has selected the team of Prometheus Research and HealthVerity to develop a new data infrastructure capable of creating the largest hub of repurposable data on epilepsy in the world.

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial (MERIT).

Agilent Technologies Inc. (NYSE: A) today introduced its first new product from recently acquired ACEA Biosciences, at the 34th Congress of the International Society for Advancement of Cytometry, CYTO 2019 Congress, being held June 22–26, 2019 in Vancouver, Canada